Syneos Health appoints Colin Shannon as CEO; Keefe remains on exec team and board

Syneos Health, Inc.

Colin Shannon appointed CEO effective October 3, 2023, succeeding Michelle Keefe.
Keefe remains a key member of the Executive Leadership Team and on the Board.
Shannon previously served as Chairman and CEO of PRA Health Sciences, leading its IPO and sale to ICON.
Keefe served as CEO for 18 months, leading the Company through its going private transaction.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Colin Shannon

Chief Executive Officer

Syneos Health, Inc.

Effective: 2023-10-03
Filed: October 3, 2023, 7:59 PM ET

Colin Shannon has been appointed Chief Executive Officer of the Company, effective immediately.

Role change

Michelle Keefe

Chief Executive Officer

Syneos Health, Inc.

Effective: 2023-10-03
Successor: Colin Shannon
Filed: October 3, 2023, 7:59 PM ET

Mr. Shannon succeeds Michelle Keefe, who will continue her tenure with the Company as a key member of the Executive Leadership Team.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Colin Shannon was appointed as Chief Executive Officer at Syneos Health, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

Colin Shannon has been appointed Chief Executive Officer of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michelle Keefe changed role as Chief Executive Officer at Syneos Health, Inc..

Action: succeeded
Role: Chief Executive Officer

Exact text from the filing

Mr. Shannon succeeds Michelle Keefe, who will continue her tenure with the Company as a key member of the Executive Leadership Team.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-23-249567

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.